Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Artiva Biotherapeutics
4747 Executive Drive #1150
San Diego, CA 92121
Phone: 858-267-4467
https://www.artivabio.com/

Artiva Biotherapeutics is a private biotech company advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, for the treatment of hematologic cancers or solid tumors. Artiva Biotherapeutics was founded on the understanding that NK cells hold enormous therapeutic potential as cancer therapies and the dedication and expertise to overcome technological barriers in the scaling and manufacturing of these cells. At Artiva, our mission is to deliver highly effective cell therapies that are also safe and immediately available and accessible to any cancer patient who stands to benefit. Artiva\'s platform delivers scalability, quality, and cryopreservation to support a pipeline of safe, effective, versatile, and accessible product candidates.

Key Contact
Name
Fred Aslan
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
06/30/20 $78,000,000 Series A 5AM Ventures
GC LabCell
Green Cross
Medivate Partners
RA Capital
VenBio
03/02/21 $120,000,000 Series B 5AM Ventures
Acuta Capital Partners
Cormorant Asset Management
EcoR1 Capital
Franklin Templeton
Janus Henderson Investors
Logos Capital
RA Capital Management
RTW Investments
Surveyor Capital
Venrock Healthcare Partners
Wellington Management Company


Featured Reading